About Joshua Resnick
Joshua Resnick is a director at PepGen.
Form D filings name Joshua Resnick as a director at Triana Biomedicines.
Joshua Resnick reports to the SEC as a director of 7 public companies, including Sionna Therapeutics (SION), Cidara Therapeutics (CDTX) and Vor Biopharma (VOR).
Joshua Resnick first appears on SEC filings in 2016.
Experience
This experience comes from SEC filings. The years are when the filings name Joshua Resnick in the role, so the role may have started earlier or lasted longer.
PI
PepGen Inc.
Director
2022 – 2026 · Public company (PEPG)
SI
Sionna Therapeutics, Inc.
Director
2025 – 2026 · Public company (SION)
CI
Cidara Therapeutics, Inc.
Director
2025 – 2026 · Public company (CDTX)
VI
Vor Biopharma Inc.
Director
2021 – 2025 · Public company (VOR)
JI
Jade Biosciences, Inc.
Director
2021 – 2024 · Public company (JBIO)
TI
Tectonic Therapeutic, Inc.
Director
2018 · Public company (TECX)
KI
KalVista Pharmaceuticals, Inc.
Director
2016 – 2017 · Public company (KALV)
Key Colleagues at Startups
The people Joshua Resnick works with at each company, as listed on that company's latest Form D.
Triana Biomedicines, Inc. · Form D, Dec 4, 2025
PT
Patrick Trojer
President and director
JR
Jigar Raythatha
Director
DG
David Grayzel
Director
AH
Andrew Hedin
Director
LK
Lorence Kim
Director
SC
Shelley Chu
Director
Christopher O'Donnell
Director